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Background: Microvascular obstruction (MVO) predicts poor outcome in ST-elevation
myocardial infarction (STEMI). Whether bolus intracoronary abciximab or manual
aspiration thrombectomy will reduce incidence and extent of MVO within the infarction
zone in STEMI is unknown.
Methods: INFUSE-AMI was a 22 factorial design trial in which patients with proximal
or mid left anterior descending (LAD) coronary artery occlusion presenting within 5 hours
of symptom onset and receiving bivalirudin anticoagulation were randomized to (1) bolus
intracoronary abciximab via the ClearWay RX catheter vs. no abciximab and (2) manual
aspiration thrombectomy with the Export catheter vs. no aspiration. A formal substudy
included 174 pts who underwent MRI imaging at both 5 and 30 days. MVO was defined
as a black area inside the zone of delayed enhancement (i.e. infarction area). This substudy
was powered for MVO size as a percentage of total left ventricular (LV) mass, assuming
50% reduction in MVO from 4% (SD 3%) in the control arm to 2% (SD1.5%) with
abciximab or thrombectomy.
Results: The extent of MVO was less than predicted in all groups, and was not affected
by treatment allocation (Table). Intracoronary abciximab improved left ventricular stroke
index at 5 days.
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Presence of MVO 51.6%
(47/
91)
60.3%
(47/
78)
0.26 59.6%
(47/
89)
51.3%
(41/
80)
0.28
MVO (% of total
LV)
0.19
[0.00,
2.39]
0.71
[0.00,
2.57]
0.54 0.67
[0.00,
2.70]
0.35
[0.00,
2.23]
0.28
Infarct mass (%
of total LV)
19.6
[11.2,
32.2]
23.7
[17.6,
31.4]
0.15 23.5
[13.3,
31.9]
20.2
[12.9,
30.2]
0.47
LV stroke volume
index (cc/m2)
43.3
[35.7,
48.7]
39.6
[34.4,
45.4]
0.05 39.6
[34.3,
45.8]
42.6
[35.7,
47.3]
0.35
LV ejection
fraction (%)
48.3
[40.3,
53.5]
47.6
[41.2,
52.5]
0.5 48.1
[40.5,
53.5]
48.2
[41.2,
53.6]
0.86
Conclusions: Neither intracoronary abciximab nor thrombectomy affected the frequency
and extent of MVO. The low extent of MVO observed with modern primary PCI and
bivalirudin anticoagulation in patients presenting early after infarct onset is notable.
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Background: No data exist regarding the comparison between manual aspiration
thrombectomy (MAT) and rheolytic thrombectomy (RT) using the optical coherence
tomography (OCT) to assess residual thrombus burden after thrombectomy in acute
myocardial infarction (AMI). The SMART trial compared the efficacy of RT and MAT
in thrombus removal before direct infarct artery stenting in AMI.
Methods: Single-center, randomized, 2-arm study. The primary end point was residual
thrombus burden assessed as number of coronary quadrants containing thrombus by OCT
after thrombectomy and before infarct artery stenting. Secondary end points were:
1) angiographic and electrocardigraphic signs of reperfusion, 2) 6-month malapposed
stent strut rate by follow-up OCT.
Results: Eighty AMI patients ( 6 hours from symptom onset) were randomly allocated
(1:1) to RT or MAT. There were no significant difference in the baseline clinical and
angiographic characteristics between the 2 study groups. All but 1 patient had residual
thrombus after MAT or RT. The number of coronary quadrants containing thrombus were
53 [31-83] in the RT arm and 65 [33-111] in MTA arm, respectively (p0.083); while
maximal thrombus area was 1.7 [0.7-2.6] and 2.0 [1.1-3.5], respectively (p0.092). Large
residual thrombus defined as the number of quadrants containing thrombus the median
value was more frequent in the MAT arm than in the RT arm (60% and 37%, p0.039).
Patients treated with RT were more likely to have a post-thrombectomy coronary TIMI
grade 3 flow (87% vs 57%; p0.003), and a lower TIMI thrombus grade (1.6  0.9 vs
2.4  1.2, p0.001) as compared to MAT. After infarct artery stenting patients
randomized to RT were more likely to have a final TIMI grade 3 flow (95% vs 80%,
p0.043) and TIMI grade 3 blush (72% vs 50%, p0.039), and early ST-segment
elevation resolution (92% vs 77%, p  0.060), as compared to MAT. The relationship
between baseline residual thrombus burden by OCT and 6-month stent strut malapposed
rate will be presented at the meeting.
Conclusions: MAT or RT allow only incomplete removal of thrombus in the setting of
AMI. RT as compared to MAT is more effective in thrombus removal and is associated
with a better myocardial reperfusion.
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Background: Infarct size (IS) is a well-established determinant of adverse LV remod-
eling. Experimental evidence indicates that attenuation of LV remodeling is critically
dependent on salvage of apoptosis-prone myocytes in the peri-infarct zone.
Methods: Thirty-one subjects (age 36-69 years) with pPCI-treated anterior STEMI, peak
TnI 138 [58-356ng/dL] (median [range]) and sustained LVEF45% were recruited. On
day 10 [7-12], 4.3x106 [0.7-9.9x106] 99mTc-extametazime-labeled CD34	 cells were
administered transcoronary (LAD). Gadolinium late-enhanced total infarct mass (IS,
cMRI) was 57 [11-112]g. One hour after administration, 1.7-9.9% labeled cells activity
localized in myocardium (whole-body -scan).
Results: Image fusion of labeled cells SPECT with LV perfusion SPECT or cMRI infarct
images indicated peri-infarct zone cell uptake. Labeled cells early engraftment correlated
with peak TnI (r0.70, p0.0001), Infarct Border Zone mass (IBZ, cMRI, r0.82,
p0.0001), total IS (r0.62, p0.0006) and severely impaired perfusion segments
number (SPECT, Ø coefficient0.83, p0.01). IBZ mass correlated with LE at 2years
(r-0.6, p0.001). LVEF was 	3.48% (p0.08 vs. baseline LVEF). With the
peri-infarct zone cell uptake proportional to IS, IS was not a determinant of LVESV
(p0.41) or LVEDV by cMRI (p0.09)(Fig, *p0.003).
Conclusions: This largest human study with labeled CD34	 cell transplantation after
recent STEMI suggests that the higher cell uptake in the peri-infarct zone in subjects with
larger infarcts might be associated with inhibition of LV remodeling. Further strategies
should focus on boosting this effect.
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